Novavax Inc
(NASDAQ:NVAX)
$5.65
0.08[1.44%]
Last update: 2:24PM (Delayed 15-Minutes)
Get Real Time Here
$5.60
-0.0500[-0.88%]
After-Hours
PerksBuyCompare Brokers
Open5.620Close-
Vol / Avg.4.514M / 7.803MMkt Cap671.165M
Day Range5.531 - 5.77052 Wk Range5.300 - 18.550

Novavax Stock (NASDAQ:NVAX), Quotes and News Summary

Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.

Open5.620Close-
Vol / Avg.4.514M / 7.803MMkt Cap671.165M
Day Range5.531 - 5.77052 Wk Range5.300 - 18.550
Avi Kapoor - 3 days ago
Adam Eckert - Nov 28, 2023, 9:08AM
Shanthi Rexaline - Nov 9, 2023, 1:22PM
Vandana Singh - Nov 9, 2023, 9:20AM
Upwallstreet - Oct 26, 2023, 2:47PM
Shanthi Rexaline - Oct 16, 2023, 2:28PM
Lisa Levin - Oct 16, 2023, 1:09PM
Vandana Singh - Oct 16, 2023, 10:35AM
Vandana Singh - Oct 16, 2023, 8:04AM
Lisa Levin - Oct 16, 2023, 7:33AM
PRNewswire - 5 days ago
PRNewswire - 5 days ago
PRNewswire - Nov 28, 2023, 6:00AM
PRNewswire - Nov 17, 2023, 7:15AM
PRNewswire - Oct 13, 2023, 9:29AM
PRNewswire - Oct 11, 2023, 8:00AM
PRNewswire - Oct 10, 2023, 9:06AM
PRNewswire - Oct 3, 2023, 3:50PM
PRNewswire - Oct 3, 2023, 3:50PM
PRNewswire - Sep 8, 2023, 4:31PM
Full archive of press releases available on Benzinga Pro
InvestorsObserver - 2 hours ago
InvestorsObserver - 3 days ago
InvestorsObserver - 4 days ago
InvestorsObserver - 5 days ago
Seeking Alpha - 5 days ago
Seeking Alpha - 6 days ago
InvestorsObserver - 6 days ago
InvestorsObserver - Dec 1, 2023, 7:03AM
InvestorPlace - Nov 30, 2023, 12:16PM
InvestorsObserver - Nov 30, 2023, 8:38AM
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-1.830-1.260 0.5700
REV158.540M186.986M28.446M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-10HC Wainwright & Co.Vernon BernardinoReiteratesBuyBuyMaintains-35.00
2023-08-09B. Riley SecuritiesMayank MamtaniUpgradesNeutralBuyAnnounces-15.00
2023-05-10HC Wainwright & Co.Vernon BernardinoReiteratesBuyLowers110.0035.00
2023-03-01B. Riley SecuritiesMayank MamtaniDowngradesBuyNeutralLowers29.0010.00

Related Companies

TickerCompanyChg %Mkt Cap
NVAXNovavax1.44%671.2M
CABACabaletta Bio5.11%731M
ETNB89bio-2.84%724.6M
VALNValneva-5.26%733M
FDMT4D Molecular Therapeutics-2.49%622.8M
Q

How do I buy Novavax (NVAX) stock?

A

You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Novavax's (NVAX) competitors?

A

Other companies in Novavax’s space includes: Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB), Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT) and Cogent Biosciences (NASDAQ:COGT).

Q

What is the target price for Novavax (NVAX) stock?

A

The latest price target for Novavax (NASDAQ: NVAX) was reported by HC Wainwright & Co. on Thursday, August 10, 2023. The analyst firm set a price target for 35.00 expecting NVAX to rise to within 12 months (a possible 519.47% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Novavax (NVAX)?

A

The stock price for Novavax (NASDAQ: NVAX) is $5.65 last updated Today at December 11, 2023 at 7:24 PM UTC.

Q

Does Novavax (NVAX) pay a dividend?

A

There is no dividend information for Novavax.

Q

When is Novavax (NASDAQ:NVAX) reporting earnings?

A

Novavax’s Q4 earnings are confirmed for Tuesday, February 27, 2024.

Q

Is Novavax (NVAX) going to split?

A

There is no upcoming split for Novavax.

Q

What sector and industry does Novavax (NVAX) operate in?

A

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.